Search research articles
Contact Us
Filters
Showing results (111-120 of 240) with videos related to
Page
of 24
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
July 26, 2014
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
American Journal of Pharmaceutical Education
|
February 21, 2012
Healthcare professional students' knowledge of drug-drug interactions
Amanda R Harrington, Terri L Warholak, Lisa E Hines, et al.
Archives of Internal Medicine
|
October 27, 2004
Health services use and health care costs of obese and nonobese individuals
Marsha A Raebel, Daniel C Malone, Douglas A Conner, et al.
The Annals of Pharmacotherapy
|
October 13, 2005
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs
Grant H Skrepnek, Jacob Abarca, Daniel C Malone, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2023
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
Steven Edelman, Jennifer Goldman, Daniel C Malone, et al.
International Journal of MS Care
|
March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosis
Kristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
Drug Safety
|
October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"
Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Research in Social & Administrative Pharmacy : RSAP
|
March 15, 2011
A drug-drug interaction knowledge assessment instrument for health professional students: a Rasch analysis of validity evidence
Terri L Warholak, J Michael Menke, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 23, 2023
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
Ainhoa Gómez Lumbreras, Malinda S Tan, Lorenzo Villa-Zapata, et al.
Page
of 24
Search research articles
Search
Showing results (111-120 of 240) with videos related to
Sort By:
Page
of 24
Journal of Managed Care & Specialty Pharmacy
|
July 26, 2014
Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
American Journal of Pharmaceutical Education
|
February 21, 2012
Healthcare professional students' knowledge of drug-drug interactions
Amanda R Harrington, Terri L Warholak, Lisa E Hines, et al.
Archives of Internal Medicine
|
October 27, 2004
Health services use and health care costs of obese and nonobese individuals
Marsha A Raebel, Daniel C Malone, Douglas A Conner, et al.
The Annals of Pharmacotherapy
|
October 13, 2005
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs
Grant H Skrepnek, Jacob Abarca, Daniel C Malone, et al.
Clinical Diabetes : a Publication of the American Diabetes Association
|
July 17, 2023
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)
Steven Edelman, Jennifer Goldman, Daniel C Malone, et al.
International Journal of MS Care
|
March 6, 2015
Lower urinary tract symptom prevalence and management among patients with multiple sclerosis
Kristin M Khalaf, Karin S Coyne, Denise R Globe, et al.
Drug Safety
|
October 12, 2022
Authors' Response to Yoshihiro Noguchi's Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)"
Daniel C Malone, Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, et al.
Research in Social & Administrative Pharmacy : RSAP
|
March 15, 2011
A drug-drug interaction knowledge assessment instrument for health professional students: a Rasch analysis of validity evidence
Terri L Warholak, J Michael Menke, Lisa E Hines, et al.
Journal of Managed Care & Specialty Pharmacy
|
September 25, 2015
Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
Haesuk Park, Karen L Rascati, Kenneth A Lawson, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
April 23, 2023
Cost-effectiveness analysis of five anti-obesity medications from a US payer's perspective
Ainhoa Gómez Lumbreras, Malinda S Tan, Lorenzo Villa-Zapata, et al.
Page
of 24